Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.76 |
| ▸ | CA9 | Q16790 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1241914 | 0.90 | CA1 (0.94) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL7053729 | 0.90 | CA1 (0.94) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL11552580 | 0.90 | CA1 (0.94) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL6346930 | 0.90 | CA1 (0.94) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL1414021 | 0.90 | CA1 (0.94) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL7055908 | 0.90 | CA1 (0.94) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL18695005 | 0.90 | CA1 (0.94) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL918482 | 0.90 | CA1 (0.94) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL189541 | 0.90 | CA1 (0.94) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL16097916 | 0.90 | CA1 (0.94) | CA1CA9ALDH1A1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115252215-A | Novel covered stent capable of improving blood flow velocity and characterization method | 上海百心安生物技术股份有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-107531790-A | Bispecific antibody capable of combining immune cells to enhance tumor killing capacity and preparation method and application thereof | 本康生物制药（深圳）有限公司 | 2018-01-02 | — | — | CN | claimed |
| EP-2137229-A2 | METHOD FOR PRODUCING LACTIC ACID POLYMERS OF HIGH CRYSTALLINITY AND MOLECULAR WEIGHT | Indian Institute of Technology, Bombay (IN) | 2009-12-30 | — | — | EP | claimed |
| WO-2009007989-A2 | METHOD FOR PRODUCING LACTIC ACID POLYMERS OF HIGH CRYSTALLINITY AND MOLECULAR WEIGHT | INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY (IN) | 2009-01-15 | — | — | WO | claimed |
| WO-2007110611-A1 | COMPOSITE MATERIAL | SMITH & NEPHEW, PLC (GB) | 2007-10-04 | — | — | WO | claimed |
| US-20070088135-A1 | Blends with shape memory characteristics | ANDREAS LEDNLEIN AND UTE RIDDER | 2007-04-19 | — | — | US | claimed |
| CN-116829203-A | Coated medical product | 亨莫特克股份公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-116710156-A | Coated medical product | 亨莫特克股份公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-115252215-A | Novel covered stent capable of improving blood flow velocity and characterization method | 上海百心安生物技术股份有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-113563569-A | Biodegradable polyester material with low melting point and preparation method and application thereof | 深圳光华伟业股份有限公司 | 2021-10-29 | — | — | CN | disclosed |
| CN-102458497-B | Catheter balloon coated with shellac and paclitaxel | 生物传感器欧洲股份公司 | 2020-11-24 | — | — | CN | disclosed |
| CN-110028655-A | Polyglycolide caprolactone copolymer ultrasonic synthetic method | 杭州华威医疗用品有限公司 | 2019-07-19 | — | — | CN | disclosed |
| CN-104017152-A | Stereocomplex polylactic acid resin composition and process for producing stereocomplex polylactic acid resin composition | MITSUI CHEMICALS INC | 2014-09-03 | — | — | CN | disclosed |
| WO-2000001307-A1 | ABSORBABLE POLYMERS AND SURGICAL ARTICLES FABRICATED THEREFROM | UNITED STATES SURGICAL CORPORATION (US) | 2000-01-13 | — | — | WO | disclosed |
| US-5626863-A | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-05-06 | — | — | US | disclosed |
| US-5567435-A | MIXING ACTIVE MATERIAL WITH A SOLUTION OF POLYMERIZABLE MACROMER COMPRISING DEGRADABLE REGION AND FREE RADICAL POLYMERIZABLE END GROUPS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1996-10-22 | — | — | US | disclosed |
| EP-0627911-A4 | PHOTOPOLYMERIZABLE BIODEGRADABLE HYDROGELS AS TISSUE CONTACTING MATERIALS AND CONTROLLED-RELEASE CARRIERS. | UNIV TEXAS (US) | 1995-07-26 | — | — | EP | disclosed |
| US-5410016-A | A curable additional polymerizable macromolecular monomers comprising at least one water soluble region, at least one degradable, hydrolyzable region and free radical polymerizable end groups; drug delivery | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-04-25 | — | — | US | disclosed |
| EP-0627911-A1 | PHOTOPOLYMERIZABLE BIODEGRADABLE HYDROGELS AS TISSUE CONTACTING MATERIALS AND CONTROLLED-RELEASE CARRIERS | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-12-14 | — | — | EP | disclosed |
| WO-1993017669-A1 | PHOTOPOLYMERIZABLE BIODEGRADABLE HYDROGELS AS TISSUE CONTACTING MATERIALS AND CONTROLLED-RELEASE CARRIERS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-09-16 | — | — | WO | disclosed |